Literature DB >> 8905251

Drug interactions with neuromuscular blockers.

S Feldman1, L Karalliedde.   

Abstract

Drugs administered to patients undergoing anaesthesia may complicate the use of the neuromuscular blockers that are given to provide good surgical conditions. The various sites of interaction include actions on motor nerve conduction and spinal reflexes, acetylcholine (ACh) synthesis, mobilisation and release, sensitivity of the motor end plate to ACh and the ease of propagation of the motor action potential. In addition, many drugs affect the pharmacokinetics of neuromuscular blockers, especially as most drugs depend to a greater or lesser extent upon renal excretion. The clinically significant interaction between nondepolarisers and depolarisers may be due to blockade of the pre-synaptic nicotinic receptors by the depolarisers, leading to decreased ACh mobilisation and release. Synergism between nondepolarisers probably results from post-synaptic receptor mechanisms. Volatile anaesthetic agents affect the sensitivity of the motor end-plate (post-synaptic receptor blockade) in addition to having effects on pre-synaptic nicotinic function. The effects of nondepolarisers are likely to be potentiated and their action prolonged by large doses of local anaesthetics due to depression of nerve conduction, depression of ACh formation, mobilisation and release, decreases in post-synaptic receptor channel opening times and reductions in muscular contraction. Most antibacterials have effects on pre-synaptic mechanisms. Procainamide and quinidine principally block nicotinic receptor channels. Magnesium has a marked inhibitory effect on ACh release. Calcium antagonists could theoretically interfere with neurotransmitter release and muscle contractility. Phenytoin and lithium decrease ACh release, whilst corticosteroids and furosemide (frusemide) tend to increase the release of the transmitter. Ecothiopate, tacrine, organophosphates, propanidid, metoclopramide and bambuterol depress cholinesterase activity and prolong the duration of the neuromuscular block. The probability of clinically significant interactions increases in patients receiving several drugs with possible effects on neuromuscular transmission and muscle contraction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905251     DOI: 10.2165/00002018-199615040-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  119 in total

1.  ANAESTHESIA FOR ATRIAL DEFIBRILLATION: EFFECT OF QUINIDINE ON MUSCULAR RELAXATION.

Authors:  A W GROGONO
Journal:  Lancet       Date:  1963-11-16       Impact factor: 79.321

2.  Comparison of the effects of general anesthethics on the end-plate of skeletal muscle.

Authors:  B E Waud; D R Waud
Journal:  Anesthesiology       Date:  1975-11       Impact factor: 7.892

3.  Ca2+ uptake and Ca2+ release by skeletal muscle sarcoplasmic reticulum: differing sensitivity to inhalational anesthetics.

Authors:  T E Nelson; T Sweo
Journal:  Anesthesiology       Date:  1988-10       Impact factor: 7.892

4.  Potentiation and antagonism of vecuronium by decamethonium.

Authors:  S Feldman; N Fauvel
Journal:  Anesth Analg       Date:  1993-03       Impact factor: 5.108

5.  The effect of prednisolone on neuromuscular transmission in the rat diaphragm.

Authors:  H Van Wilgenburg
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

6.  [Etomidate and suxamethonium. The duration of relaxation and pseudocholinesterase activity. A clinical experimental study (author's transl)].

Authors:  A Doenicke; I Dittmann-Kessler; A Sramoto; E Beyer
Journal:  Anaesthesist       Date:  1980-03       Impact factor: 1.041

7.  Prolonged neuromuscular blockade following trimetaphan infusion. A case report and in vitro study of cholinesterase inhibition.

Authors:  K Nakamura; M Koide; T Imanaga; H Ogasawara; M Takahashi; M Yoshikawa
Journal:  Anaesthesia       Date:  1980-12       Impact factor: 6.955

8.  The comparative influence of gamma-hydroxy butyric acid, althesin and etomidate on the neuromuscular blocking potency of pancuronium in man.

Authors:  L H Booij; J F Crul
Journal:  Acta Anaesthesiol Belg       Date:  1979-12

9.  Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.

Authors:  J Engbaek; H Ording; T Pedersen; J Viby-Mogensen
Journal:  Br J Anaesth       Date:  1984-09       Impact factor: 9.166

10.  Lithium and neuromuscular transmission.

Authors:  B E Waud; L Farrell; D R Waud
Journal:  Anesth Analg       Date:  1982-05       Impact factor: 5.108

View more
  9 in total

Review 1.  Organophosphorus poisoning (acute).

Authors:  Peter G Blain
Journal:  BMJ Clin Evid       Date:  2011-05-17

Review 2.  Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions.

Authors:  D A Flockhart; Z Desta; S K Mahal
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

Review 3.  The safety and tolerability of donepezil in patients with Alzheimer's disease.

Authors:  Stephen Jackson; Richard J Ham; David Wilkinson
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 4.  Organophosphorus poisoning (acute).

Authors: 
Journal:  BMJ Clin Evid       Date:  2007-03-01

Review 5.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

6.  Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS).

Authors:  Marco Schlepütz; Annette D Rieg; Sophie Seehase; Jan Spillner; Alberto Perez-Bouza; Till Braunschweig; Thomas Schroeder; Marc Bernau; Verena Lambermont; Christina Schlumbohm; Katherina Sewald; Rüdiger Autschbach; Armin Braun; Boris W Kramer; Stefan Uhlig; Christian Martin
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Effect of dexamethasone on the onset time and recovery profiles of cisatracurium.

Authors:  Keum Young So; Sang Hun Kim; Ki Tae Jung; Dong Woo Kim
Journal:  Korean J Anesthesiol       Date:  2017-01-12

Review 8.  Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents.

Authors:  Yong Beom Kim; Tae-Yun Sung; Hong Seuk Yang
Journal:  Korean J Anesthesiol       Date:  2017-09-28

9.  Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial.

Authors:  Tom Schepens; Koen Janssens; Sabine Maes; Davina Wildemeersch; Jurryt Vellinga; Philippe G Jorens; Vera Saldien
Journal:  BMC Anesthesiol       Date:  2019-10-19       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.